Argitalpenak (239)

¹ Taldearen produkzio gisa hartzen diren argitalpenak.

Ikerketa datu erreferentziatuak ikusi.

filter_list

2025

  1. Academias médicas en Salamanca y otras academias

    Ediciones de la Diputación de Salamanca

  2. Association between cigarette smoking, genetic polymorphism and myelodysplasia: a multicentric case-control study

    Medicina Clinica, Vol. 164, Núm. 5, pp. 211-216

  3. C3G promotes bone marrow adipocyte expansion and hematopoietic regeneration after myeloablation by enhancing megakaryocyte niche function

    Journal of Hematology and Oncology, Vol. 18, Núm. 1

  4. Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding

    Biomolecules, Vol. 15, Núm. 12

  5. Correction: Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis (Cell Death & Disease, (2025), 16, 1, (711), 10.1038/s41419-025-08031-y)

    Cell Death and Disease

  6. Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis

    Cell Death and Disease, Vol. 16, Núm. 1

  7. Estudio funcional y molecular de una paciente con macrotrombocitopenia asociada a SLFN14

    XI Jornadas de Investigadoras de Castilla y León: la aventura de la ciencia y tecnología (Servicio de Publicaciones e Imagen Institucional), pp. 85

  8. Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model

    Biomolecules, Vol. 15, Núm. 5

  9. Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

    British Journal of Haematology, Vol. 207, Núm. 4, pp. 1565-1577

  10. Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response

    Journal of Pathology, Vol. 265, Núm. 4, pp. 502-517

  11. Prospective study of continuous rhythm monitoring in patients with early post-infarction systolic dysfunction: clinical impact of arrhythmias detected by an implantable cardiac monitoring device with real-time transmission-the TeVeO study protocol

    BMJ open, Vol. 15, Núm. 5, pp. e094764